RMTI
ROCKWELL MEDICAL, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$8.05
−0.49%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.92x
- Price / sales
- 0.47x
- Price / cash flow
- 11.20x
Enterprise value
- Enterprise value
- $21.6M
- EV / sales
- 0.31x
- EV / EBITDA
- -11.62x
- EV / EBIT
- -4.77x
- Market cap
- $32.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026